Understanding type 2 diabetes: from genetics to epigenetics

Acta Diabetologica

Volumn 52, Issue 5, 2015, Pages 821-827

  Raciti, Gregory Alexander ^a,b   Longo, Michele ^a,b   Parrillo, Luca ^a,b   Ciccarelli, Marco ^a,b   Mirra, Paola ^a,b   Ungaro, Paola ^a,b   Formisano, Pietro ^a,b   Miele, Claudia ^a,b   Béguinot, Francesco ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

Epigenetics; Histone modifications; Methylation; MicroRNA; Personalized medicine; Type 2 diabetes

Indexed keywords

DNA; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN KINASE C ALPHA;

AGE; ARTICLE; CELL FUNCTION; DISEASE MODEL; DISEASE TRANSMISSION; DNA MODIFICATION; EATING HABIT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIGENETICS; EPIGENOTYPE; EXERCISE; FTO GENE; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; INSULIN SENSITIVITY; LEUKOCYTE; LIFESTYLE MODIFICATION; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PEA 15 GENE; PREDICTION; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SMOKING; ANIMAL; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; ENVIRONMENT; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; INSULIN RESISTANCE; LIFESTYLE; MOUSE; PHENOTYPE;

ANIMALS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIFE STYLE; MICE; PHENOTYPE;

EID: 84941935616     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-015-0741-0     Document Type: Article

References (49)

1. Kirchner H, Osler ME, Krook A, Zierath JR (2013) Epigenetic flexibility in metabolic regulation: disease cause and prevention? Trends Cell Biol 23(5):203–209
2. Schwenk RW, Vogel H, Schürmann A (2013) Genetic and epigenetic control of metabolic health. Mol Metab 2(4):337–347
3. Ungaro P, Mirra P, Oriente F, Nigro C, Ciccarelli M, Vastolo V, Longo M, Perruolo G, Spinelli R, Formisano P, Miele C, Beguinot F (2012) Peroxisome proliferator-activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1. J Biol Chem 287(51):42951–42961
4. Ungaro P, Teperino R, Mirra P, Cassese A, Fiory F, Perruolo G, Miele C, Laakso M, Formisano P, Beguinot F (2008) Molecular cloning and characterization of the human PED/PEA-15 gene promoter reveal antagonistic regulation by hepatocyte nuclear factor 4alpha and chicken ovalbumin upstream promoter transcription factor II. J Biol Chem 283(45):30970–30979
5. Oriente F, Fernandez Diaz LC, Miele C, Iovino S, Mori S, Diaz VM, Troncone G, Cassese A, Formisano P, Blasi F, Beguinot F (2008) Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism. Mol Cell Biol 28(18):5634–5645
6. Oriente F, Iovino S, Cabaro S, Cassese A, Longobardi E, Miele C, Ungaro P, Formisano P, Blasi F, Beguinot F (2011) Prep1 controls insulin glucoregulatory function in liver by transcriptional targeting of SHP1 tyrosine phosphatase. Diabetes 60(1):138–147
7. Oriente F, Cabaro S, Liotti A, Longo M, Parrillo L, Pagano TB, Raciti GA, Penkov D, Paciello O, Miele C, Formisano P, Blasi F, Beguinot F (2013) PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice. Diabetologia 56(12):2713–2722
8. Szyf M (2007) The dynamic epigenome and its implications in toxicology. Toxicol Sci 100(1):7–23
9. Cooper ME, El-Osta A (2010) Epigenetics: mechanisms and implications for diabetic complications. Circ Res 107(12):1403–1413
10. Paneni F, Costantino S, Volpe M, Lüscher TF, Cosentino F (2013) Epigenetic signatures and vascular risk in type 2 diabetes: a clinical perspective. Atherosclerosis 230(2):191–197
11. Piarulli F, Sartore G, Lapolla A (2013) Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. Acta Diabetol 50(2):101–110
12. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ (2010) Chronic high-fat diet in fathers programs β-cell dysfunction in female rat offspring. Nature 467(7318):963–966
13. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B, Wainstein J, Friedlander Y, Levy-Lahad E, Glaser B, Hellman A (2012) Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 21(2):371–383
14. International Diabetes Federation (2013) IDF diabetes atlas, 6th edn. Brussels, Belgium
15. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, 2010 China Noncommunicable Disease Surveillance Group (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959
16. Billings LK, Florez JC (2010) The genetics of type 2 diabetes: what have we learned from GWAS? Ann NY Acad Sci 1212:59–77
17. Raciti GA, Nigro C, Longo M, Parrillo L, Miele C, Formisano P, Béguinot F (2014) Personalized medicine and type 2 diabetes: lesson from epigenetics. Epigenomics 6(2):229–238
18. Zierath JR, Barrès RE (2011) Nutritional status affects the epigenomic profile of peripheral blood cells. Epigenomics 3(3):259–260
19. Bennett PH (1990) Epidemiology of diabetes mellitus. In: Rifkin H, Porte D Jr (eds) Ellenberg and Rifkin’s diabetes mellitus, 4th edn. Elsevier, New York, pp 363–370
20. InterAct Consortium, Scott RA, Langenberg C, Sharp SJ, Franks PW, Rolandsson O, Drogan D, van der Schouw YT, Ekelund U, Kerrison ND, Ardanaz E, Arriola L, Balkau B, Barricarte A, Barroso I, Bendinelli B, Beulens JW, Boeing H, de Lauzon-Guillain B, Deloukas P, Fagherazzi G, Gonzalez C, Griffin SJ, Groop LC, Halkjaer J, Huerta JM, Kaaks R, Khaw KT, Krogh V, Nilsson PM, Norat T, Overvad K, Panico S, Rodriguez-Suarez L, Romaguera D, Romieu I, Sacerdote C, Sánchez MJ, Spijkerman AM, Teucher B, Tjonneland A, Tumino R, van der DL A, Wark PA, McCarthy MI, Riboli E, Wareham NJ (2013) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56(1):60–69
21. Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham offspring study. Diabetes 49(12):2201–2207
22. Klein BE, Klein R, Moss SE, Cruickshanks KJ (1996) Parental history of diabetes in a population-based study. Diabetes Care 19(8):827–830
23. Barnett AH, Eff C, Leslie RD, Pyke DA (1981) Diabetes in identical twins. A study of 200 pairs. Diabetologia 20(2):87–93
24. Knowles NG, Landchild MA, Fujimoto WY, Kahn SE (2002) Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 25(2):292–297
25. Raciti GA, Beguinot F (2015) Epigenetics of T2DM. Diapedia. http://www.diapedia.org/3105513816/rev/3. Accessed 09 Feb 2015
26. De Jesus DF, Kulkarni RN (2014) Epigenetic modifiers of islet function and mass. Trends Endocrinol Metab 25(12):628–636
27. Harris MI (1989) Impaired glucose tolerance in the US population. Diabetes Care 12:464–474
28. Joost HG (2008) Pathogenesis, risk assessment and prevention of type 2 diabetes mellitus. Obes Facts 1(3):128–137
29. Vigliotta G, Miele C, Santopietro S, Portella G, Perfetti A, Maitan MA, Cassese A, Oriente F, Trencia A, Fiory F, Romano C, Tiveron C, Tatangelo L, Troncone G, Formisano P, Beguinot F (2004) Overexpression of the ped/pea-15 gene causes diabetes by impairing glucose-stimulated insulin secretion in addition to insulin action. Mol Cell Biol 24(11):5005–5015
30. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F, Cafieri A, Tecce MF, Formisano P, Beguinot L, Beguinot F (1998) PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J 17(14):3858–3866
31. Condorelli G, Vigliotta G, Trencia A, Maitan MA, Caruso M, Miele C, Oriente F, Santopietro S, Formisano P, Beguinot F (2001) Protein kinase C (PKC)-α activation inhibits PKC-ζ and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells. Diabetes 50(6):1244–1252
32. Miele C, Raciti GA, Cassese A, Romano C, Giacco F, Oriente F, Paturzo F, Andreozzi F, Zabatta A, Troncone G, Bosch F, Pujol A, Chneiweiss H, Formisano P, Beguinot F (2007) PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes 56(3):622–633
33. Dunn GA, Bale TL (2011) Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology 152(6):2228–2236
34. Barrès R, Yan J, Egan B, Treebak JT, Rasmussen M, Fritz T, Caidahl K, Krook A, O’Gorman DJ, Zierath JR (2012) Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab 15(3):405–411
35. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A, Näslund E, Zierath JR (2013) Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 3(4):1020–1027
36. Rönn T, Volkov P, Davegårdh C, Dayeh T, Hall E, Olsson AH, Nilsson E, Tornberg A, Dekker Nitert M, Eriksson KF, Jones HA, Groop L, Ling C (2013) A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet 9(6):e1003572
37. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C, Rodford J, Slater-Jefferies JL, Garratt E, Crozier SR, Emerald BS, Gale CR, Inskip HM, Cooper C, Hanson MA (2011) Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 60(5):1528–1534
38. Ling C, Del Guerra S, Lupi R, Rönn T, Granhall C, Luthman H, Masiello P, Marchetti P, Groop L, Del Prato S (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51(4):615–622
39. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10(3):189–198
40. Yang BT, Dayeh TA, Kirkpatrick CL, Taneera J, Kumar R, Groop L, Wollheim CB, Nitert MD, Ling C (2011) Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 54(2):360–367
41. Yang BT, Dayeh TA, Volkov PA, Kirkpatrick CL, Malmgren S, Jing X, Renström E, Wollheim CB, Nitert MD, Ling C (2012) Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 26(7):1203–1212
42. Liu ZH, Chen LL, Deng XL, Song HJ, Liao YF, Zeng TS, Zheng J, Li HQ (2012) Methylation status of CpG sites in the MCP-1 promoter is correlated to serum MCP-1 in type 2 diabetes. J Endocrinol Invest 35(6):585–589
43. Stepanow S, Reichwald K, Huse K, Gausmann U, Nebel A, Rosenstiel P, Wabitsch M, Fischer-Posovszky P, Platzer M (2011) Allele-specific, age-dependent and BMI-associated DNA methylation of human MCHR1. PLoS One 6(5):e17711
44. Souren NY, Tierling S, Fryns JP, Derom C, Walter J, Zeegers MP (2011) DNA methylation variability at growth-related imprints does not contribute to overweight in monozygotic twins discordant for BMI. Obesity 19(7):1519–1522
45. Kuehnen P, Mischke M, Wiegand S, Sers C, Horsthemke B, Lau S, Keil T, Lee YA, Grueters A, Krude H (2012) An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet 8(3):e1002543
46. Zhao J, Goldberg J, Vaccarino V (2013) Promoter methylation of serotonin transporter gene is associated with obesity measures: a monozygotic twin study. Int J Obes 37(1):140–145
47. Groom A, Potter C, Swan DC, Fatemifar G, Evans DM, Ring SM, Turcot V, Pearce MS, Embleton ND, Smith GD, Mathers JC, Relton CL (2012) Postnatal growth and DNA methylation are associated with differential gene expression of the TACSTD2 gene and childhood fat mass. Diabetes 61(2):391–400
48. Relton CL, Groom A, St Pourcain B, Sayers AE, Swan DC, Embleton ND, Pearce MS, Ring SM, Northstone K, Tobias JH, Trakalo J, Ness AR, Shaheen SO, Smith GD (2012) DNA methylation patterns in cord blood DNA and body size in childhood. PLoS One 7(3):e31821
49. Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92(6):707–715